Form 4: Guardian Pharmacy Services Director Reports Conversion of Class B Common Stock to Class A

John Ackerman, a director of Guardian Pharmacy Services, reported the conversion of Class B common stock into Class A common stock, as per the company's Amended and Restated Certificate of Incorporation.

Summary

• John Ackerman, a director at Guardian Pharmacy Services, filed a Form 4 detailing changes in beneficial ownership.
• The transactions involve the conversion of Class B common stock into Class A common stock.
• These conversions occurred on March 28, 2025, and are part of a pre-defined schedule.
• The conversions are happening in four substantially equal tranches on specific dates.
• Ackerman indirectly owns these securities through Pharmacy Investors, LLC and Cardinal Equity Fund, L.P.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing, indicating a pre-planned conversion of stock. It doesn't inherently suggest positive or negative sentiment.

Future Outlook

The remaining Class B shares will convert to Class A shares in three more tranches on September 27, 2025, March 28, 2026, and September 27, 2026.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, ensuring transparency and compliance with SEC regulations.

Stakeholder Impact

• The conversion of Class B shares to Class A shares may have a slight impact on the overall share structure, but the effect is likely minimal due to the pre-planned nature of the conversion.

Key Dates

Keywords

Form 4, Beneficial Ownership, Class B Common Stock, Class A Common Stock, Guardian Pharmacy Services, Conversion, Director, Ackerman, Pharmacy Investors LLC, Cardinal Equity Fund L.P.